Autolus Therapeutics (AUTL) Current Leases (2019 - 2025)

Autolus Therapeutics (AUTL) has 7 years of Current Leases data on file, last reported at $4.6 million in Q4 2025.

• For the quarter ending Q4 2025, Current Leases rose 52.27% year-over-year to $4.6 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (up 52.27% YoY), and the FY2025 full-year result was $4.6 million, up 52.27% from the prior year.
• Current Leases for Q4 2025 stood at $4.6 million, down from $4.8 million in the prior quarter.
• Across five years, Current Leases topped out at $6.2 million in Q2 2023 and bottomed at $3.0 million in Q1 2025.
• The 5-year median for Current Leases is $4.5 million (2021), against an average of $4.4 million.
• The widest annual swing landed in 2023, when Current Leases jumped 55.97%; it then slumped 40.67% in 2024.
• A 5-year view of Current Leases shows it stood at $4.5 million in 2021, then grew by 13.14% to $5.0 million in 2022, then grew by 0.3% to $5.1 million in 2023, then plunged by 40.67% to $3.0 million in 2024, then surged by 52.27% to $4.6 million in 2025.
• The last three Current Leases figures came in at $4.6 million (Q4 2025), $4.8 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.

Peer Comparison